Precision BioSciences, Inc.
Precision BioSciences, Inc. (DTIL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DTIL · as of Jun 9, 2026
Key Statistics
Explore Precision BioSciences, Inc. Data
dtil stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 75.0%
The DTIL analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $19.00, representing +180.65% upside from the current price of $6.77.
Competitors & Peers
dtil competitorsDTIL
ADVM
ALXO
ARTV
ATYR
CNTBStock Performance
Full HistoryAbout Precision BioSciences, Inc.
Precision BioSciences, Inc. is a clinical-stage biotechnology firm based in the United States, specializing in the creation of both in vivo gene editing solutions and ex vivo allogeneic CAR T-cell the…
what is precision biosciences, inc. · dtil stock overview · precision biosciences, inc. company profile · who is precision biosciences, inc. ceo · dtil NASDAQ · precision biosciences, inc. headquarters · precision biosciences, inc. business segments
About Stock Overview & Key Data
Precision BioSciences, Inc. (DTIL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 28, 2019. As of the latest trading session, DTIL stock price is $6.77, with a market capitalization of $86.8M. The stock has returned +27.74% over the past 12 months and +62.74% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Precision BioSciences, Inc. stock is Buy, with an average 12-month price target of $19.00. In fiscal year 2025, Precision BioSciences, Inc. reported revenue of $34.3M and net income of -$46.6M. For detailed data — including Precision BioSciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Precision BioSciences, Inc. (DTIL) stock price is $6.77. The stock is traded on NASDAQ under the ticker symbol DTIL. The 52-week range is $3.53 – $8.82.